1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. Switzerland >
  5. Recordati Acquires Pro Farma AG

M&A Deal Summary

Recordati Acquires Pro Farma AG

On July 14, 2016, Recordati acquired life science company Pro Farma AG for 16M CHF

Acquisition Highlights
  • This is Recordati’s 10th transaction in the Life Science sector.
  • This is Recordati’s 11th largest (disclosed) transaction.
  • This is Recordati’s 1st transaction in Switzerland.

M&A Deal Summary
Date 2016-07-14
Target Pro Farma AG
Sector Life Science
Buyer(s) Recordati
Deal Type Add-on Acquisition
Deal Value 16M CHF

Target

Pro Farma AG

Baar, Switzerland
Pro Farma AG is a pharmaceutical company. Pro Farma specialties in selected therapeutic areas which include both prescription and OTC drugs. The main brands are Lacdigest (tilactase), Tretinac (isotretinoin) and Urocit (potassium citrate).

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Recordati

Milan, Italy
Category Company
Founded 1926
Sector Medical Products
Employees4,450
Revenue 2.3B EUR (2024)
DESCRIPTION

Recordati is an international pharmaceutical group dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in the main European countries, in Russia, other Central and Eastern European countries, Turkey, North Africa, the United States of America, Canada, Mexico and in some South American countries. An efficient field force of medical representatives promotes a wide range of innovative pharmaceuticals, both proprietary and under license, in a number of therapeutic areas including a specialized business dedicated to treatments for rare diseases. Recordati was founded in 1926 and is based in Milan, Italy.

DEAL STATS #
Overall 16 of 17
Sector: Life Science M&A 10 of 10
Type: Add-on Acquisition M&A Deals 14 of 15
Country: Switzerland M&A 1 of 1
Year: 2016 M&A 2 of 2
Size (of disclosed) 11 of 13
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-05-31 Italchimici

Metropolitan City, Italy

Italchimici SpA is a pharmaceutical company. Italchimici’s wide-ranging product portfolio includes, among other brands, Reuflor, Peridon, Perido Natural and Lacdigest in the gastroenterological area and Aircort and Cexidal in the respiratory area.

Buy €130M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-12-21 Tonipharm S.A.S.

Boulogne-Billancourt, France

Tonipharm S.A.S. promotes a wide portfolio of self-medication products together with some prescription drugs. The company’s sales are generated mainly by the line of products sold under the umbrella brand Ginkor, OTC treatments based on ginko biloba which are very well known on the French market. The company also promotes Alodont®, a line of products used for oral hygiene.

Buy -
Mergr

Solution for

Product

Company

Legal